My mental arithmetic recons that 22 million shares is 1% of the company, not .001%
For every buyer, there has been a seller, and the price flat.
Hard to get big $$$'s set other than some systematic accumulation on market, unless one of the biggest shareholders want to bail out.
That seems unlikely given the amended business plan and encouraging progression of the science on multiple fronts.
We should also remember that chunky investors who had owned the stock prior to the last capital raising are still well underwater with a minimum weighted average holding price of ~2.1 cents (calculated as 3.2 cents prior to trading halt, 1 for 1 at 1 cent issue price etc)
My instinct tells me that plenty must have been happening recently with new consultants, and executives, animal trials, and Genetech over the last 6 months, and shareholders are totally in the dark.
I'm sweating on the next shareholder update due in October in the hope of it shedding a much brighter light on what has been going on behind all those scenes.
PYC Price at posting:
1.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)